Kihara James bought ACAD
March 6, 2026 · Form 4 insider transaction
Kihara James bought 6,332 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,332
Price
$0.00
Total value
N/A
InsiderKihara James
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 6, 2026
Filing dateMarch 10, 2026
Shares owned after6,332
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.; The restricted stock units vest in four equal annual installments beginning March 6, 2027.